Other languages DarioHealth Corp.

Equities

DRIO

US23725P2092

Delayed Nasdaq Other stock markets 12:25:26 2024-06-06 pm EDT			5-day change	1st Jan Change
1.41 ^USD	+4.44%		-3.42%	-18.02%

Jun. 05	DarioHealth Appoints Steven Nelson as Chief Commercial Officer	MT
Jun. 05	DarioHealth Corp. Announces Management Changes	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DarioHealth Appoints Steven Nelson as Chief Commercial Officer	Jun. 05
DarioHealth Corp. Announces Management Changes	Jun. 05
DarioHealth Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	Apr. 25
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	Apr. 18
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	Apr. 10
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	Apr. 02
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	Mar. 12
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	Feb. 21
DarioHealth Corp. acquired Twill, Inc. for $34.4 million.	Feb. 20
DarioHealth to Provide Diabetes, Weight-Control Services for Food Services Union Members	Jan. 11
Regional Union Selects DarioHealth Corp.'s Cardiometabolic Solution for Diabetes, Hypertension, Weight Management and GLP-1 Support	Jan. 11
National Employer Selects Dariohealth Corp. Cardiometabolic and GLP-1 Solutions to Improve Employee Health	Dec. 05
DarioHealth Corp. Contracts with New Employer for Cardiometabolic Solution	Nov. 27
Los analistas financieros, ávidos de tratamientos contra la obesidad	Nov. 20
Les analystes financiers avides de traitements anti-obésité	Nov. 20
DarioHealth Corp. Provides Revenue Guidance for the Year 2024	Nov. 02
DarioHealth Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 02
DarioHealth Launches New Blood Sugar Meter for Apple iPhone 15 Users	Nov. 01

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages DarioHealth Corp.

Equities

DRIO

US23725P2092

Other languages

Filters